MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.360
-0.090
-2.02%
Opening 10:37 01/19 EST
OPEN
4.560
PREV CLOSE
4.450
HIGH
4.570
LOW
4.350
VOLUME
131.24K
TURNOVER
--
52 WEEK HIGH
5.40
52 WEEK LOW
1.330
MARKET CAP
113.69M
P/E (TTM)
-9.6099
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Seeking Alpha Catalyst Watch
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a
Seekingalpha · 3d ago
Anixa Biosciences to Present at the B. Riley Oncology Investor Conference
, /PRNewswire/ --  (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Dr. , Anixa's Chief Executive Officer, will present at B. Riley's Inaugural Oncology Investor Confer...
PR Newswire - PRF · 6d ago
Anixa Biosciences to Present at the B. Riley Oncology Investor Conference
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Dr. Amit Kumar, Anixa's Chief Executive Officer, will present at B. Riley's Inaugural Oncology I...
PR Newswire · 6d ago
Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Dr. Amit Kumar, Anixa's Chief Executive Officer, will present at the virtual H.C. Wainwright Bio...
PR Newswire · 01/05 13:30
Thinking about buying stock in Sportsman's Warehouse, FireEye, Fubotv, Anixa Biosciences, or Velodyne Lidar?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPWH, FEYE, FUBO, ANIX, and VLDR.
PR Newswire - PRF · 12/22/2020 13:35
MARA, PTON, QS and VLDR among premarket gainers
Aurora Mobile (JG) +85% after company inks partnership with new EV manufactures.Aemetis (AMTX) +61% after company acquired ~20% ownership of Nevo Motors.Hudson Capital (HUSN) +40% after issuing revenue guidance for FreightHub.Sportsman's Warehouse Holdings (SPWH) +37% after entering into
Seekingalpha · 12/22/2020 13:24
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
, /PRNewswire/ --  (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) applicati...
PR Newswire - PRF · 12/21/2020 13:30
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) appli...
PR Newswire · 12/21/2020 13:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ANIX. Analyze the recent business situations of Anixa Biosciences Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ANIX stock price target is 8.75 with a high estimate of 9.00 and a low estimate of 8.50.
EPS
Institutional Holdings
Institutions: 31
Institutional Holdings: 1.85M
% Owned: 7.10%
Shares Outstanding: 26.08M
TypeInstitutionsShares
Increased
4
123.79K
New
10
137.53K
Decreased
5
31.73K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.61%
Pharmaceuticals & Medical Research
+1.23%
Key Executives
Chairman/President/Chief Executive Officer/Director
Amit Kumar
Chief Financial Officer/Chief Operating Officer/IR Contact Officer
Michael Catelani
Executive Vice President
Thomas Schlumpberger
Lead Director/Independent Director
Lewis Titterton
Independent Director
John Monanhan
Independent Director
Arnold Baskies
Independent Director
David Cavalier
Independent Director
Emily Gottschalk
Independent Director
John Monahan
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ANIX
Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Anixa Biosciences Inc stock information, including NASDAQ:ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.